Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

Eye
Jost B JonasImren Akkoyun

Abstract

To report on visual outcome of patients receiving an intravitreal injection of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. The prospective comparative nonrandomized clinical interventional study included 187 consecutive patients with progressive exudative age-related macular degeneration, divided into a study group of 115 patients receiving an intravitreal injection of 25 mg triamcinolone acetonide, and a control group of 72 patients without treatment. The mean follow-up was 6.0+/-4.2 months. Visual acuity increased significantly (P=0.03) in the study group, and decreased significantly (P=0.01) in the control group, at 1 month and 3 months after start of the study. Between the study group and control group, the differences in change of visual acuity were significant (P=0.001). In the study group, the number of patients with an increase in visual acuity of 2 or more Snellen lines was significantly (P=0.001) larger than in the control group. Correspondingly, the number of patients with a decrease of 2 or more Snellen lines was significantly (P=0.007) smaller in the study group. In all, 43 (37.4%) patients of the study group experienced an increase in best visual acuity by 2 or m...Continue Reading

References

May 1, 1988·Survey of Ophthalmology·N M BresslerS L Fine
May 11, 1989·La Revue du praticien·G Soubrane, G Coscas
Jan 1, 1980·American Journal of Ophthalmology·Y TanoR Machemer
Apr 1, 1982·American Journal of Ophthalmology·R H SchindlerR Machemer
Dec 1, 1980·American Journal of Ophthalmology·Y TanoR Machemer
Feb 1, 1995·Ophthalmology·J R VingerlingP T de Jong
Jan 1, 1993·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A N AntoszykD L Hatchell
Dec 8, 1998·Australian and New Zealand Journal of Ophthalmology·J K ChallaF A Billson
Jan 21, 2000·Australian and New Zealand Journal of Ophthalmology·R J Wingate, P E Beaumont
Sep 1, 2000·The British Journal of Ophthalmology·J B JonasS Panda-Jonas
Mar 29, 2001·Clinical & Experimental Ophthalmology·S YoungS Lightman
Sep 1, 2001·American Journal of Ophthalmology·J B Jonas, A Söfker
Sep 20, 2001·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·J B JonasS Panda-Jonas
Jan 30, 2002·The British Journal of Ophthalmology·Paul B GreenbergElias Reichel
Nov 1, 1995·Australian and New Zealand Journal of Ophthalmology·P L PenfoldF A Billson
May 3, 2002·Ophthalmology·Adam MartidisCaroline Baumal
May 30, 2002·The British Journal of Ophthalmology·P L Penfold
Aug 20, 2002·The British Journal of Ophthalmology·Jost B Jonas
Sep 25, 2002·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Jost B JonasRobert F Degenring
Nov 30, 2002·Journal of Cataract and Refractive Surgery·Jost B Jonas, Antje Söfker
Dec 19, 2002·The British Journal of Ophthalmology·J B JonasR Degenring
Jan 14, 2003·Archives of Ophthalmology·Jost B JonasRobert F Degenring
Jan 29, 2003·Journal of Cataract and Refractive Surgery·Mandi D ConwayGholam A Peyman
Feb 5, 2003·American Journal of Ophthalmology·Nathanael BenhamouAlain Gaudric
Feb 25, 2003·The British Journal of Ophthalmology·R F Degenring, J B Jonas
Mar 19, 2003·The British Journal of Ophthalmology·J B JonasR Degenring
May 14, 2003·Archives of Ophthalmology·Jost B JonasRobert Degenring
Jul 16, 2003·Acta Ophthalmologica Scandinavica·Robert F DegenringJost B Jonas
Jul 31, 2003·American Journal of Ophthalmology·Jost B JonasRobert F Degenring
Sep 2, 2003·European Journal of Ophthalmology·J B JonasR F Degenring

❮ Previous
Next ❯

Citations

May 25, 2013·Nature Reviews. Immunology·Jayakrishna AmbatiBradley D Gelfand
Mar 8, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Igor KozakWilliam R Freeman
Jul 1, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jost B JonasUrs Vossmerbaeumer
Nov 2, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jost B JonasFrank Schlichtenbrede
Jul 21, 2006·The British Journal of Ophthalmology·M D Conway
Nov 21, 2007·Drugs & Aging·Albert J Augustin, Indre Offermann
Feb 27, 2008·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A Frimpong-BoatengJ Roider
Oct 19, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Jost B Jonas, Matthias Schmidbauer
Apr 7, 2006·Ocular Immunology and Inflammation·Bram van KooijPhilip de Vries
Oct 27, 2006·Expert Opinion on Emerging Drugs·Albert J Augustin, Indre Offermann
Dec 17, 2009·Expert Opinion on Pharmacotherapy·Chih-Hung KuoMark Gillies
Jul 9, 2009·Retina·Gholam A PeymanDarius M Moshfeghi
Jul 11, 2007·Retina·Yaron LangIdo Perlman
Aug 28, 2007·Survey of Ophthalmology·C M JermakG A Peyman
May 4, 2007·Experimental Eye Research·Peter SzurmanMartin S Spitzer
Jan 17, 2007·Ophthalmology·Yaron LangIdo Perlman
Feb 17, 2007·American Journal of Ophthalmology·Tongalp H TezelHenry J Kaplan
Dec 5, 2006·Experimental Eye Research·Jose M Ruiz-MorenoManuel Vidal
Jun 11, 2005·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Eugene W M Ng, Anthony P Adamis
Feb 24, 2006·Clinical Therapeutics·Helen Kourlas, Daryl S Schiller
Oct 14, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Naveed YasinIlva D Rupenthal
Jun 24, 2006·Current Opinion in Ophthalmology·Stephen M Conti, Peter J Kertes
Jun 10, 2006·Ophthalmic Research·Jost B Jonas
Oct 13, 2007·European Journal of Ophthalmology·W Chang, M Chung
Jun 10, 2005·European Journal of Ophthalmology·J B JonasR F Degenring
Nov 4, 2016·Acta Ophthalmologica·Jin-Da WangWei Zhang
Jun 9, 2006·European Journal of Ophthalmology·J M Ruiz-MorenoS Barile
Aug 27, 2010·Acta Ophthalmologica·Rutledge Ellis-Behnke, Jost B Jonas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.